Nova Cell, Inc. /
Calidi Biotherapeutics, Inc.
Nova Cell, Inc. agrees to buy Calidi Biotherapeutics, Inc.
Source for the buyer and target: Calidi Biotherapeutics, Inc.
For the buyer and target.
“On October 27, 2025, Calidi Biotherapeutics, Inc. (the “Company”) entered into that certain Stock Repurchase Agreement (the “SRA”) and Material Purchase Agreement (the “MPA” and together with the SRA the “Agreements”), with its majority owned subsidiary, Nova Cell, Inc. (“Nova Cell”).”
Published 31 Oct 2025
Open the sourceWhat happened
Nova Cell, Inc. agreed to acquire Calidi Biotherapeutics, Inc. for $6,000,000, according to a filing dated Oct. 31, 2025. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Nova Cell, Inc. agrees to buy Calidi Biotherapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“Nova Cell, Inc. agrees to buy Calidi Biotherapeutics, Inc. Nova Cell, Inc. agreed to acquire Calidi Biotherapeutics, Inc. for $6,000,000, according to a filing dated Oct. 31, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly